Developer of cloud-based self-insurance platform intended to evolve the way in which health benefits work
Developer of cloud-based self-insurance platform intended to evolve the way in which health benefits work
Business/Productivity Software📍 San Francisco, CAFounded 2013
Current Valuation
$1.5B
as of 2021-Q2
UNICORN
QL Price
$418.05M
-73% vs last round
QuantLogix's current estimate for Collective Health, published 2026-09-27 — below the last disclosed round of $1.5B (2021-Q2).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$1.5B
2021-Q2
weight 0.03
Secondary market print
$367.2M
2026-06-27
weight 0.58
How this price has held up
No round has priced for Collective Health since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Collective Health, 2026-09-27 (4a5dad37c1fb4892).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Collective Health going public?
No. Collective Health is private and has not filed to go public. There is no S-1 on file.
What is Collective Health's valuation in 2026?
Collective Health is valued at $1.5B as of 2021-Q2, set by its Series F ($280M, May 2021). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Collective Health filed an S-1?
No public S-1 is on file for Collective Health.
How much has Collective Health raised?
Collective Health has raised $755M in total, most recently a Series F of $280M in May 2021.
Is Collective Health publicly traded — can you buy Collective Health stock?
No. Collective Health is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Collective Health on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2013
HQ
San Francisco, CA
Employees
799
Total Raised
$755M
Last Round
Series F — $280M (May 2021)
IPO Status
private
Fundraising Status
Series F · $280M · 5y 4mo ago
privateTotal raised $755M
Secondary Market
Implied price / share
$0.18
Last round price / share
$0.75
vs last round
-76.0%
Open interest
1
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series F
$280M
May 2021
—
$1.5B
Talent Signal
Hiring trend
▼ Hiring downtrend
-81% vs 2026-08
Open roles
3
via greenhouse
Product-build share
67%
engineering, research, product, design
Trajectory
tightening
heavy product build — 67% of open roles are product-building functions (engineering/research/product) — 1 of 3 open roles are other.
Open roles trending down; no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Group Product Manager, Core TPA ClaimsLead Security Analyst-GRCDirector of Analytics
Counted from Collective Health's live job board as of 2026-09-16; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Health CareHealth InsuranceInsurTech
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q2. Refreshed quarterly.